From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’
The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological approach relied on aggressive...
Search results for "targeted therapy"
Unmasking Glioblastoma’s Accomplice: Researchers Identify Hidden Protein Network Driving Brain Tumor Recurrence
"I had surgery and I even went through radiation—so why did it come back?" Families of glioblastoma patients face this devastating question time and...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs
A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.
Datroway Approved: New Targeted Therapy Offers Hope for Metastatic Breast Cancer
A new therapeutic horizon has arrived for patients battling metastatic breast cancer that has progressed despite...
Cell and Gene Therapy Advances Take Center Stage at Samsung Joint International Symposium
Leading researchers developing stem cell and extracellular vesicle therapies for sepsis, personalized mRNA vaccines for...
“One Eye Sees Fine, so It Goes Unnoticed”: How Anisometropia Endangers Children's Vision
Even when two eyes do not see equally well, many people navigate daily life without obvious trouble as long as one eye...
At 48, Looking Like She’s Still in Her 20s: Actor Ha Ji-won Shares Her Anti-Aging Secrets
Actor Ha Ji-won recently shared her personal skincare routine for maintaining skin firmness and elasticity.
Radiation Therapy Shrinks Lymph-Node Tumors in 75% of Advanced Liver Cancer Cases
When hepatocellular carcinoma spreads to the lymph nodes, it is classified as advanced liver cancer, typically...
Rapid PCR Test Cuts Treatment Decision Time by 41 Hours in Severe Bloodstream Infections
When bacteria or fungi causing conditions like pneumonia or urinary tract infections invade the bloodstream, they...
Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone
For patients with aggressive blood cancers that recur or fail to respond to standard chemotherapy, chimeric antigen...